10-K: CareView Communications Reports Increased Revenue in 2023 Annual Results

Sentiment:

Annual Results


CareView Communications, Inc. reports a significant increase in revenue for the year ended December 31, 2023, driven by sales-based contracts.

Capital raiseManagement will look to continue funding operations by increased sales volumes and raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements.
Worse than expectedThe company has a significant working capital deficit and a history of net losses and cash outflows, raising substantial doubt about its ability to continue as a going concern.

Summary

  • CareView Communications, Inc. experienced a revenue increase of approximately $1.783 million for the year ended December 31, 2023, compared to 2022.
  • The increase in revenue was primarily due to a rise in sales-based contracts for equipment and software bundles, which increased by $1.969 million and $545,681 respectively, while subscription revenue decreased by $731,909.
  • The company's operating loss was approximately $688,000 for 2023, compared to $1.27 million in 2022.
  • Net loss for 2023 was approximately $3.952 million, a decrease from $6.042 million in 2022.
  • The company's backlog for sales-based contracts as of December 31, 2023, is approximately $5.403 million, with $3.274 million expected to be billed in 2024.
  • The monthly subscription-based billable amount as of December 31, 2023, is approximately $293,000 under contract and $57,500 month to month, with a total annual subscription billable of approximately $4.206 million expected for 2024.
  • As of December 31, 2023, the company had a working capital deficit of $37,263,645.

Sentiment

Score: 4

Explanation: While the company shows revenue growth and reduced losses, the significant working capital deficit and going concern uncertainty temper the positive aspects. The company's reliance on future funding and the material weakness in internal controls also contribute to a lower sentiment score.

Positives

  • The company experienced a significant increase in revenue due to the adoption of sales-based contracts.
  • Operating and net losses decreased compared to the previous year.
  • The company has a substantial backlog of sales-based contracts, indicating future revenue potential.
  • The company has secured multiple group purchasing agreements with major healthcare organizations, expanding its market reach.

Negatives

  • The company has a significant working capital deficit.
  • The company's subscription-based revenue decreased in 2023.
  • The company has a history of net losses and cash outflows.
  • The company's financial statements raise substantial doubt about its ability to continue as a going concern.

Risks

  • The company's ability to continue as a going concern is dependent on securing additional funding and achieving positive cash flow.
  • The company is subject to risks associated with healthcare technology companies, including dependence on key individuals, product development, and competition.
  • The company's financial results are dependent on a few major customers.
  • The company's internal controls over financial reporting were deemed ineffective as of December 31, 2023, due to material weaknesses.

Future Outlook

The company anticipates continued growth in sales-based contracts and expects approximately $4.206 million in total annual subscription billable revenue for 2024. Management will look to continue funding operations by increased sales volumes and raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements.

Management Comments

  • CareView is redefining the standard of patient safety in hospitals and healthcare facilities across the country.
  • CareView has proven that its innovative technology is creating a culture of patient safety where patient falls have decreased by 80% with sitter costs reduced by more than 65%.
  • Hybrid patient care, the combination of bedside and virtual care, allows hospitals to keep nurses working at the top of their licenses and creates flexible and scalable workforce options.
  • The shift in our new contracting model has an immediate impact on the company's operations resulting in greater cash flow within 30 days of contract signing.

Industry Context

The company's focus on remote patient monitoring and virtual nursing aligns with the growing demand for telehealth solutions and addresses staffing shortages in the healthcare industry. The company's technology is positioned to capitalize on the trend towards hybrid patient care models.

Comparison to Industry Standards

  • CareView competes with companies like Cisco Systems, Avasure, Caregility, Royal Philips Electronics, and Cerner Corporation in the clinical video monitoring space.
  • CareView differentiates itself through its patented Virtual Bed Rails and Virtual Chair Rails technology, which aims to reduce patient falls and sitter requirements.
  • Unlike some competitors that offer physical sensors or beds with fall alarms, CareView provides a video-based fall prevention system.
  • The company claims its system provides significant cost savings, reductions in patient falls, and improved patient care compared to alternatives.

Related Party Transactions

  • Our directors, officers, principal shareholders, and associate or affiliate completed a debt-to-equity conversion between March and May 2023.

Stakeholder Impact

  • Shareholders face uncertainty due to the company's going concern status and financial challenges.
  • Employees may be affected by potential cost-cutting measures or restructuring.
  • Customers may benefit from the company's innovative technology and cost-saving solutions.
  • Creditors face increased risk due to the company's financial instability.

Next Steps

  • The company will continue to work with Vizient on new contracts.
  • Management will look to continue funding operations by increased sales volumes and raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements.

Key Dates

DateDescription
1997-07-08CareView Communications, Inc. was originally formed as Purpose, Inc.
1999-04The company changed its name to Ecogate, Inc.
2006-01-26L. Allen Wheeler became a Director of CareView.
2006-04-11Steven G. Johnson was elected as a Director and appointed as Chief Executive Officer, President, Secretary, and Treasurer.
2007-10The company changed its name to CareView Communications, Inc.
2009-09-08The company entered into a Commercial Lease Agreement for office and warehouse space.
2011-04-21Jeffrey C. Lightcap was elected as a Director of CareView.
2014-01-01Jason T. Thompson and David R. White were elected as Directors of CareView.
2014-04-01Steven B. Epstein and Dr. James R. Higgins were elected as Directors of CareView.
2016-12-14The company entered a Group Purchasing Agreement with HealthTrust Purchasing Group, L.P.
2017-01-01The Group Purchasing Agreement with HealthTrust Purchasing Group, L.P. became effective.
2018-02-02The company partnered with Decisive Point Consulting Group, LLC.
2018-10-01CareView Connect was added to the HealthTrust GPO Agreement.
2020-11-01The updated contracting model was added to the HealthTrust GPO Agreement.
2021-09-10The company entered an Indefinite Delivery Indefinite Quality (IDIQ) contract for Telecare Services.
2021-12-01The HealthTrust GPO Agreement was renewed for another 3 year term.
2021-11-30The company and Rockwell entered into a Sixth Amendment to the Rockwell Note.
2022-06-08The company entered a Group Purchasing Agreement with Premier, Inc.
2022-06-15The Group Purchasing Agreement with Premier, Inc. became effective.
2022-10-17CareView received innovative Technology designation.
2023-02-15The company entered a Group Purchasing Agreement with Vizient.
2023-03-29The company had 63 employees on a full-time basis.
2023-03-30Noteholders converted Replacement Notes into shares of common stock.
2023-05-22The company amended its articles of incorporation to increase the authorized shares.
2023-05-24Noteholders presented Conversion Notices to convert Replacement Notes into shares of common stock.
2023-12-22The company entered a Vetted Partner Agreement with Panda Health, Inc.
2024-01-01The Vetted Partner Agreement with Panda Health, Inc. became effective.
2024-03-05The board of directors approved 29,837,858 stock option grants.
2024-03-29The company had 583,880,748 outstanding shares of common stock.

Keywords

patient safety, video monitoring, healthcare technology, sales-based contracts, subscription revenue, virtual nursing, telehealth, long-term care, fall prevention, remote patient monitoring

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.